Controlled trial evaluates recovery from muscle damage in volleyball players, suggesting targeted nutraceutical benefits.
In highly trained male volleyball athletes, short-term POMj did not outperform placebo on group-mean recovery outcomes at 48 h post-EIMD; however, SWC-based analyses showed a higher proportion of meaningful responders with POMj in selected high-velocity isokinetic measures, supporting responder-focused evaluations of recovery nutraceuticals in sport-specific settings.
No takes yet. Share an insight, caveat, or question.
Rezaei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: